Aknar Calabrich

Real-world disparities in molecular diagnosis of diffuse gliomas in Brazil: Insights from LACOG 0619

Camilla Akemi Felizardo Yamada, Marcos Vinícius Calfat Maldaun, Fabiana Spilari Viola, Clarissa Baldotto et autres

us, br, pe, co (code pays fourni par la source)

Treatment of ALK+ Non–Small Cell Lung Cancer in the Brazilian Public and Private Health Care Systems: A Tale of Inequalities (LACOG/GBOT 1918)

Eldsamira Mascarenhas, Ana Caroline Zimmer Gelatti, T. Montella, Marcelo Corassa et autres

br, es, us (code pays fourni par la source)

Relacorilant and Nab-Paclitaxel in Patients With Platinum-Resistant Ovarian Cancer (ROSELLA): An Open-label, Randomized, Controlled, Phase 3 Trial

Alexander Olawaiye, Laurence Gladieff, David M. O’Malley, Jae‐Weon Kim et autres

EP.13.28 Assessment of Clinical Characteristics and Outcomes of Brazilian ES-SCLC Patients on First Line Durvalumab + Chemotherapy

D. Lopes, Marcelo Corassa, Aknar Calabrich, B. Lafayette et autres

br, us (code pays fourni par la source)

1127P Randomized phase II study of induction nivolumab plus ipilimumab followed by nivolumab with chemoradiotherapy versus standard of care chemoradiotherapy for women with locally advanced cervical cancer: Analysis of the response rate to induction immunotherapy in the experimental arm

Henrique Alkalay Helber, Carla Rameri Alexandre Silva de Azevedo, Andréia Cristina de Melo, R. Ribeiro et autres

br (code pays fourni par la source)

A phase II trial of palbociclib plus letrozole after progression on second-line chemotherapy for women with hormone receptor-positive high-grade serous or endometrioid ovarian, fallopian tube, or peritoneal cancer (LACOG 1018)

Fernanda Damian, Andréia Cristina de Melo, Graziela Zibetti Dal Molin, Angélica Nogueira‐Rodrigues et autres

br, us (code pays fourni par la source)

Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial

Alexander Olawaiye, Laurence Gladieff, David M. O’Malley, Jae‐Weon Kim et autres

us, fr, kr, ar, it, ca, au, be, es, gb, hu, in, pl (code pays fourni par la source)

Guidelines of the Brazilian Society of Surgical Oncology for anatomopathological, immunohistochemical, and molecular testing in female tumors

Reitan Ribeiro, Filomena Marino Carvalho, Glauco Baiocchi, Rodrigo Santa Cruz Guindalini et autres

br (code pays fourni par la source)

Capítulo 14

Aknar Calabrich

P2.16-04 Assessment of the Efficacy and Safety of Durvalumab Associated with Platinum-Etoposide in Previously Untreated ES-SCLC in Brazil

D. Lopes, Mauro Zukin, Aknar Calabrich, V. Cordeiro de Lima et autres

EGFR Mutation Detection in Brazilian Patients With Non–Small-Cell Lung Cancer: Lessons From Real-World Data Scenario of Molecular Testing

T. Montella, Mariano Zalis, Mauro Zukin, Vladmir Cláudio Cordeiro de Lima et autres

br (code pays fourni par la source)

A phase II trial of palbociclib combined to letrozole after progression on second-line chemotherapy for women with ER/PR-positive high-grade serous or endometrioid ovarian, fallopian tube, or peritoneal cancer: LACOG 1018.

Fernanda Damian, Andréia Cristina de Melo, Graziela Zibetti Dal Molin, Angélica Nogueira Rodrigues et autres

br (code pays fourni par la source)